We are live on ! Find out more
DRTX

DURATA THERAPEUTICS INC COM STK (DE)
DRTX

Delisted

DRTX was delisted on the 17th of November, 2014.

46 hedge funds and large institutions have $164M invested in DURATA THERAPEUTICS INC COM STK (DE) in 2013 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

149% more capital invested

Capital invested by funds: $65.8M → $164M (+$97.9M)

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

14% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 14

4% less funds holding

Funds holding: 4846 (-2)

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

Holders
46
Holders Change
-2
Holders Change %
-4.17%
% of All Funds
1.33%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
6
Increased
16
Reduced
14
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$324K +$129K +12,300 +95%
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$302K +$2.1K +200 +0.9%
Deutsche Bank
28
Deutsche Bank
Germany
$296K -$352K -33,557 -59%
SKK
29
Shepherd Kaplan Krochuk
Massachusetts
$247K
TA
30
Teachers Advisors
New York
$234K +$15.1K +1,440 +9%
RhumbLine Advisers
31
RhumbLine Advisers
Massachusetts
$157K
KCM
32
Kanawha Capital Management
Virginia
$141K
JMPWA
33
JP Morgan Private Wealth Advisors
California
$128K
AIG
34
American International Group
New York
$124K -$913 -87 -0.9%
LWA
35
Lenox Wealth Advisors
New York
$102K
Morgan Stanley
36
Morgan Stanley
New York
$82K -$73K -6,960 -52%
BA
37
BlackRock Advisors
Delaware
$81K +$3.43K +327 +5%
Citigroup
38
Citigroup
New York
$80K +$63.3K +6,037 +3,112%
TRCT
39
Tower Research Capital (TRC)
New York
$38K -$20.1K -1,918 -39%
LTFS
40
Ladenburg Thalmann Financial Services
Florida
$13K
GI
41
Gradient Investments
Minnesota
$13K +$10.5K +1,000 New
U
42
UBS
Switzerland
$5K -$14.2K -1,357 -77%
Barclays
43
Barclays
United Kingdom
$3K -$2.08K -198 -40%
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
$2.15K +$1.76K +168 New
AllianceBernstein
45
AllianceBernstein
Tennessee
$2K -$9.44K -900 -86%
Manulife (Manufacturers Life Insurance)
46
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$165 +$127K +12,098 +1,628%
GPP
47
Great Point Partners
Connecticut
-$4.6M -508,472 Closed
DM
48
Deerfield Management
New York
-$2.5M -275,979 Closed
SIP
49
Stoneridge Investment Partners
Pennsylvania
-$278K -30,732 Closed
PAM
50
Paradigm Asset Management
New York
-$226K -25,000 Closed

DRTX Hedge Fund Activity: Q4 2013 in Review

46 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in DURATA THERAPEUTICS INC COM STK (DE) (DRTX) for Q4 2013, worth a combined $164M — up 149% from $65.8M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of DRTX and 6 opened new positions — a net loss of 2 holders — while 14 trimmed existing stakes and 16 added.

The largest buyer was Wellington Management Group, adding an estimated $13M. The largest seller was Great Point Partners, exiting entirely with an estimated $4.6M sold.

  • 46 institutional investors held DURATA THERAPEUTICS INC COM STK (DE) (DRTX) as of Q4 2013, down from 48 in Q3 2013.
  • Funds reported $164M of DURATA THERAPEUTICS INC COM STK (DE) stock for Q4 2013, up 149% quarter-over-quarter.
  • 6 funds opened new DURATA THERAPEUTICS INC COM STK (DE) positions in Q4 2013 and 8 closed out, a net change of -2 holders.
  • The largest DURATA THERAPEUTICS INC COM STK (DE) buyer in Q4 2013 was Wellington Management Group, an estimated $13M added.
  • The largest DURATA THERAPEUTICS INC COM STK (DE) seller in Q4 2013 was Great Point Partners, an estimated $4.6M sold.

Based on aggregated 13F filings for Q4 2013.